Gilot David, Loyer Pascal, Corlu Anne, Glaise Denise, Lagadic-Gossmann Dominique, Atfi Azeddine, Morel Fabrice, Ichijo Hidenori, Guguen-Guillouzo Christiane
INSERM U522, Régulation des Equilibres fonctionnels du foie Normal et Pathologique, Avenue de la Bataille Flandre/Dunkerque, Hôpital Pontchaillou, 35033 Rennes, France.
J Biol Chem. 2002 Dec 20;277(51):49220-9. doi: 10.1074/jbc.M207325200. Epub 2002 Oct 4.
Hepatoprotection mediated by free radical scavenging molecules such as dimethyl sulfoxide (Me(2)SO) arose the question as to whether this effect involved one or several anti-apoptotic signals. Here, using primary cultures of rat hepatocytes and in vivo thioacetamide-induced liver failure, we showed that Me(2)SO failed to prevent any cleavage of initiator caspase-8 and -9 but constantly inhibited procaspase-3 maturation and apoptosis execution, pointing to an efficient inhibition of cleaved initiator caspase activities. Evidence was recently provided that apoptosis might require both caspase and ASK1/JNK-p38 activities. We demonstrated that this kinase pathway was strongly inhibited in the presence of Me(2)SO whereas overexpression of ASK1 was able to restore caspase-3 activity and apoptosis. Interestingly, we also found that GST M1/2 and GST Alpha1/2 dropped under apoptotic conditions; furthermore transfection of GST M1, A1, or P1 to cells overexpressing ASK1, abolished caspase-3 activity and restored viability. This role of GSTs was further assessed by showing that their high expression level was tightly associated with inhibition of ASK1 activity in Me(2)SO-protected hepatocytes. Together, these results demonstrate that Me(2)SO-mediated hepatoprotection involves a dual inhibition of cleaved initiator caspase and ASK1/JNK-p38 activities. Furthermore, in highlighting the control of apoptosis by GSTs, these data provide new insights for analyzing the complex mechanisms of hepatoprotection.
由自由基清除分子如二甲基亚砜(Me(2)SO)介导的肝脏保护作用引发了一个问题,即这种效应是否涉及一个或多个抗凋亡信号。在这里,我们使用大鼠原代肝细胞培养物和体内硫代乙酰胺诱导的肝衰竭模型,发现Me(2)SO不能阻止起始半胱天冬酶-8和-9的任何切割,但能持续抑制前半胱天冬酶-3的成熟和凋亡执行,表明其能有效抑制切割后的起始半胱天冬酶活性。最近有证据表明,凋亡可能需要半胱天冬酶和ASK1/JNK-p38活性。我们证明,在Me(2)SO存在的情况下,这条激酶途径受到强烈抑制,而ASK1的过表达能够恢复半胱天冬酶-3的活性和凋亡。有趣的是,我们还发现,在凋亡条件下,谷胱甘肽S-转移酶M1/2和谷胱甘肽S-转移酶Alpha1/2水平下降;此外,将谷胱甘肽S-转移酶M1、A1或P1转染到过表达ASK1的细胞中,可消除半胱天冬酶-3的活性并恢复细胞活力。通过显示它们的高表达水平与Me(2)SO保护的肝细胞中ASK1活性的抑制紧密相关,进一步评估了谷胱甘肽S-转移酶的这种作用。总之,这些结果表明,Me(2)SO介导的肝脏保护作用涉及对切割后的起始半胱天冬酶和ASK1/JNK-p38活性的双重抑制。此外,这些数据突出了谷胱甘肽S-转移酶对凋亡的控制,为分析肝脏保护的复杂机制提供了新的见解。